Literature DB >> 30734133

Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.

Worth Longest1,2, Dale Farkas3.   

Abstract

Computational fluid dynamics (CFD) modeling offers a powerful tool for the development of drug delivery devices using a first principles approach but has been underutilized in the development of pharmaceutical inhalers. The objective of this study was to develop quantitative correlations for predicting the aerosolization behavior of a newly proposed dry powder inhaler (DPI). The dose aerosolization and containment (DAC) unit DPI utilizes inlet and outlet air orifices designed to maximize the dispersion of spray-dried powders, typically with low air volumes (~ 10 mL) and relatively low airflow rates (~ 3 L/min). Five DAC unit geometries with varying orifice outlet sizes, configurations, and protrusion distances were considered. Aerosolization experiments were performed using cascade impaction to determine mean device emitted dose (ED) and mass median aerodynamic diameter (MMAD). Concurrent CFD simulations were conducted to predict both flow field-based and particle-based dispersion parameters that captured different measures of turbulence. Strong quantitative correlations were established between multiple measures of turbulence and the experimentally observed aerosolization metrics of ED and MMAD. As expected, increasing turbulence produced increased ED with best case values reaching 85% of loaded dose. Surprisingly, decreasing turbulence produced an advantageous decrease in MMAD with values as low as approximately 1.6 μm, which is in contrast with previous studies. In conclusion, CFD provided valuable insights into the performance of the DAC unit DPI as a new device including a two-stage aerosolization process offering multiple avenues for future enhancements.

Entities:  

Keywords:  aerosol delivery to children; aerosolization with low air volumes; dry powder inhalers; pharmaceutical aerosols; quantitative analysis and design; spray-dried powders

Mesh:

Substances:

Year:  2019        PMID: 30734133      PMCID: PMC7276205          DOI: 10.1208/s12248-018-0281-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  35 in total

1.  Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.

Authors:  P Worth Longest; Geng Tian; Ross L Walenga; Michael Hindle
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

2.  Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers.

Authors:  Jagdeep Shur; Sau Lee; Wallace Adams; Robert Lionberger; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2012-06-22       Impact factor: 4.009

3.  Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Judy A Raper
Journal:  J Pharm Sci       Date:  2006-06       Impact factor: 3.534

4.  In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.

Authors:  Christophe Duret; Nathalie Wauthoz; Romain Merlos; Jonathan Goole; Calliope Maris; Isabelle Roland; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Eur J Pharm Biopharm       Date:  2012-04-20       Impact factor: 5.571

5.  Validating CFD predictions of respiratory aerosol deposition: effects of upstream transition and turbulence.

Authors:  P Worth Longest; Samir Vinchurkar
Journal:  J Biomech       Date:  2006-03-14       Impact factor: 2.712

6.  Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.

Authors:  Zhen Xu; Heidi M Mansour; Tako Mulder; Richard McLean; John Langridge; Anthony J Hickey
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

7.  In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth-Throat Models and In Vitro-In Vivo Correlations for a Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler.

Authors:  Xiangyin Wei; Michael Hindle; Anubhav Kaviratna; Bao K Huynh; Renishkumar R Delvadia; Dennis Sandell; Peter R Byron
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-06-07       Impact factor: 2.849

8.  In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.

Authors:  Renishkumar Delvadia; Michael Hindle; P Worth Longest; Peter R Byron
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-09-04       Impact factor: 2.849

Review 9.  In silico models of aerosol delivery to the respiratory tract - development and applications.

Authors:  P Worth Longest; Landon T Holbrook
Journal:  Adv Drug Deliv Rev       Date:  2011-05-27       Impact factor: 15.470

10.  Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.

Authors:  Zhen Xu; Heidi M Mansour; Tako Mulder; Richard McLean; John Langridge; Anthony J Hickey
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

View more
  8 in total

1.  Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.

Authors:  Worth Longest; Dale Farkas; Karl Bass; Michael Hindle
Journal:  Pharm Res       Date:  2019-05-28       Impact factor: 4.200

2.  Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

Authors:  Dale Farkas; Michael Hindle; Serena Bonasera; Karl Bass; Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-08-29       Impact factor: 2.849

3.  Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates.

Authors:  Connor Howe; Mohammad A M Momin; Dale R Farkas; Serena Bonasera; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2021-08-30       Impact factor: 4.580

4.  In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants.

Authors:  Connor Howe; Mohammad A M Momin; Karl Bass; Ghali Aladwani; Serena Bonasera; Michael Hindle; Philip Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2022-02-14       Impact factor: 3.440

5.  Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.

Authors:  Karl Bass; Dale Farkas; Worth Longest
Journal:  AAPS PharmSciTech       Date:  2019-11-01       Impact factor: 3.246

6.  High-Efficiency Dry Powder Aerosol Delivery to Children: Review and Application of New Technologies.

Authors:  Karl Bass; Dale Farkas; Amr Hassan; Serena Bonasera; Michael Hindle; P Worth Longest
Journal:  J Aerosol Sci       Date:  2020-10-14       Impact factor: 3.433

Review 7.  Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications.

Authors:  Zhanying Zheng; Sharon Shui Yee Leung; Raghvendra Gupta
Journal:  Pharmaceutics       Date:  2021-02-01       Impact factor: 6.321

8.  Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.

Authors:  Connor Howe; Michael Hindle; Serena Bonasera; Vijaya Rani; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-08-04       Impact factor: 2.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.